Market Newsdesk

SPRINGFIELD, Mo., Dec. 18, 2020 (GLOBE NEWSWIRE) — Guaranty Federal Bancshares, Inc., (NASDAQ:GFED), the holding company (the “Company”) for Guaranty Bank, today announces a dividend per common share of $.15 for its fourth quarter ending December 31, 2020. The dividend will be payable on January 15, 2021 to stockholders of record on January 5, 2021.

About Guaranty Federal Bancshares, Inc.


Guaranty Federal Bancshares, Inc. (NASDAQ:GFED) has a subsidiary corporation offering full banking services. The principal subsidiary, Guaranty Bank, is headquartered in Springfield, Missouri, and has 16 full-service branches in Greene, Christian, Jasper and Newton Counties and a Loan Production Office in Webster County. Guaranty Bank is a member of the MoneyPass ATM network which provides its customers surcharge free access to over 32,000 ATMs nationwide. For more information visit the Guaranty Bank website: www.gbankmo.com.

The Company may from time to time make written or oral “forward-looking statements,” including statements contained in the Company’s filings with the SEC, in its reports to stockholders and in other communications by the Company, which are made in good faith by the Company pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates,” “estimates,” “believes,” “expects,” and similar expressions are intended to identify such forward-looking statements but are not the exclusive means of identifying such statements.

These forward-looking statements involve risks and uncertainties, such as statements of the Company’s plans, objectives, expectations, estimates and intentions, that are subject to change based on various important factors (some of which are beyond the Company’s control). The following factors, among others, could cause the Company’s financial performance to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements:

● the strength of the United States economy in general and the strength of the local economies in which we conduct operations;

● the effects of, and changes in, trade, monetary and fiscal policies and laws, including interest rate policies of the Federal Reserve, inflation, interest rates, market and monetary fluctuations;

● the timely development of and acceptance of new products and services and the perceived overall value of these products and services by users, including the features, pricing and quality compared to competitors’ products and services;

● the willingness of users to substitute competitors’ products and services for our products and services;

● our success in gaining regulatory approval of our products and services, when required;

● the impact of changes in financial services laws and regulations (including laws concerning taxes, banking, securities and insurance);

● technological changes;

● the ability to successfully manage and integrate any future acquisitions if and when our board of directors and management conclude any such acquisitions are appropriate;

● changes in consumer spending and saving habits;

● our success at managing the risks resulting from these factors; and

● other factors set forth in reports and other documents filed by the Company with the SEC from time to time.

Contacts:

Shaun A. Burke, President and CEO or Carter M. Peters, CFO 2144 E. Republic Road, Suite F200 Springfield, MO 65804 1.833.875.2492

AUSTIN, Texas, Dec. 18, 2020 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the company will participate in the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021.

H.C. Wainwright BioConnect 2021 Conference
Date:	January 11, 2021
What:	Lumos Pharma Presentation
A webcast of Lumos Pharma’s presentation will be available on-demand as of 6:00AM ET, Monday, January 11, 2021, through the H.C. Wainwright conference portal and on Lumos Pharma’s website under “Events & Presentations” in the Investors & Media section.  The webcast will be available on Lumos Pharma’s website for 30 days.

No one-on-one meetings will be held at the presentation – only H.C. Wainwright BioConnect 2021 Conference. Investors are invited to contact Lumos Pharma Investor Relations directly to schedule one-on-one meetings with management.

About Lumos Pharma

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding by leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma’s lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU. For more information, please visit www.lumos-pharma.com.

Investor & Media Contact:

Lisa Miller
Lumos Pharma Investor Relations
512-792-5454
[email protected]

Source: Lumos Pharma, Inc.

 

NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer announced today that it has entered into a distribution agreement with Swixx BioPharma AG (“Swixx”) to be the exclusive distributor of the Company’s antibodies, DANYELZA® (naxitamab-gqgk) for the treatment of patients with relapsed/refractory high-risk neuroblastoma and omburtamab, if approved, for the treatment of pediatric patients with CNS/leptomeningeal metastasis from neuroblastoma in Eastern Europe, including Russia. DANYELZA (naxitamab-gqgk) 40mg/10mL was approved by the U.S. Food and Drug Administration (“FDA”) on November 25, 2020 and is indicated, in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF”), for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy. The Company plans to resubmit its (“BLA”) to the FDA for omburtamab by the end of 2020 or in early 2021.

The distribution agreement includes the European territories of Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Russia, Serbia, Slovakia and Slovenia. Under the terms of the agreement, Swixx will employ its sales and marketing expertise to distribute DANYELZA and omburtamab, if approved, in the territory. In addition, Swixx will submit registration files on behalf of Y-mAbs in certain parts of the territory. All other unpartnered geographies worldwide remain with the Company. Financial details were not disclosed.

“We are very pleased to enter this distribution agreement with Swixx, and hope to see a DANYELZA and omburtamab, if approved, being made available to appropriate children with unmet medical needs in Eastern Europe and Russia,” said Thomas Gad, founder, Chairman and President at Y-mAbs.

Researchers at Memorial Sloan Kettering Cancer Center (“MSK”) developed DANYELZA and omburtamab, which are exclusively licensed by MSK to Y-mAbs. As a result of this licensing arrangement, MSK has institutional financial interests in the compounds and in Y-mAbs.

About DANYELZA® (naxitamab-gqgk)

DANYELZA (naxitamab-gqgk) is indicated, in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF”), for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy. This indication was approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefits in a confirmatory trial. DANYELZA includes a Boxed Warning for serious infusion-related reactions, such as cardiac arrest and anaphylaxis, and neurotoxicity, such as severe neuropathic pain and transverse myelitis. See full Prescribing Information for complete Boxed Warning and other important safety information.

About Y-mAbs

Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including one FDA approved product, DANYELZA® (naxitamab-gqgk), which targets tumors that express GD2, and one pivotal-stage product candidate, omburtamab, which targets tumors that express B7-H3.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about our business model and development, commercialization and product distribution plans; current and future clinical and pre-clinical studies and our research and development programs; expectations related to the timing of the initiation and completion of regulatory submissions; regulatory, marketing and reimbursement approvals; rate and degree of market acceptance and clinical utility as well as pricing and reimbursement levels; retaining and hiring key employees; our commercialization, marketing and manufacturing capabilities and strategy; our intellectual property position and strategy; additional product candidates and technologies; collaborations or strategic partnerships and the potential benefits thereof; expectations related to the use of our cash and cash equivalents, and the need for, timing and amount of any future financing transaction; our financial performance, including our estimates regarding revenues, expenses, capital expenditure requirements; developments relating to our competitors and our industry; and other statements that are not historical facts. Words such as ‘‘anticipate,’’ ‘‘believe,’’ “contemplate,” ‘‘continue,’’ ‘‘could,’’ ‘‘estimate,’’ ‘‘expect,’’ “hope,” ‘‘intend,’’ ‘‘may,’’ ‘‘might,’’ ‘‘plan,’’ ‘‘potential,’’ ‘‘predict,’’ ‘‘project,’’ ‘‘should,’’ ‘‘target,’’ “will”, ‘‘would’’ and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our product candidates and related technologies are novel approaches to cancer treatment that present significant challenges. Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including but not limited to: risks associated with our financial condition and need for additional capital; risks associated with our development work; cost and success of our product development activities and clinical trials; the risks of delay in the timing of our regulatory submissions or failure to receive approval of our drug candidates; the risks related to commercializing any approved pharmaceutical product including the rate and degree of market acceptance of our product candidates; development of our sales and marketing capabilities and risks associated with failure to obtain sufficient reimbursement for our products; the risks related to our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; the risks related to government regulation; risks related to market approval, risks associated with protection of our intellectual property rights; risks related to employee matters and managing growth; risks related to our common stock, risks associated with the pandemic caused by the novel coronavirus known as COVID-19 and other risks and uncertainties affecting the Company including those described in the “Risk Factors” section included in our Annual Report on Form 10-K and in our other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

“DANYELZA” and “Y-mAbs” are registered trademarks of Y-mAbs Therapeutics, Inc.

Contact:

Y-mAbs Therapeutics, Inc.

230 Park Avenue, Suite 3350

New York, NY 10169

USA

+1 646 885 8505

E-mail: [email protected]

 

VANCOUVER, British Columbia, Dec. 18, 2020 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to report very favourable results from its current step-out and infill drilling programs. The current programs have demonstrated a material expansion of several mineralized zones, most notably at Japoneses, Buena Suerte, Veta de Oro, El Rincon and El Colorado (see map below). Based on these results, the Company is revising the parameters for a planned Preliminary Economic Assessment (PEA) to assess the viability of Heap Leach Mining Operation (HLMO) by increasing the target conceptual capacity from 8,000 tonnes per day (tpd) to 20,000 tpd.

A map accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/578776ff-118f-47d4-a4f9-3c408b2d32ea

On November 18, 2020, Sonoro reported engaging McClelland Laboratories of Sparks, Nevada to conduct independent metallurgical testing of the mineralization at Cerro Caliche for its upcoming NI 43-101 compliant mineral resource update and PEA based on all drilling results to December 15, 2020. Sonoro expects that this independent metallurgical testing will confirm and expand on the results of its preliminary in-house column leach tests.

As reported on December 8, 2020, and as a key component of fast-tracking the proposed Cerro Caliche mine development, Sonoro contracted D.E.N.M. Engineering Ltd. to prepare a NI 43-101 compliant PEA and Micon International Limited to prepare an NI 43-101 compliant updated resource estimate, based on all drill results up until December 15, 2020. The realization of the Company’s goal of commencing gold production by December 2021 remains dependent on several material conditions, most notably the satisfactory completion of the current metallurgical testing, a favourable PEA report, securing required environmental permitting and securing project financing.

El Colorado Zone – Assay results

Sonoro reports the following results from the current drilling program at El Colorado:

• SCD-008 intercepted 11.7 m averaging 0.92 g/t Au, including 4.55 m averaging 1.84 g/t Au,
• SCD-016 intercepted 11.25 m averaging 1.08 g/t Au including 1 m averaging 2.88 g/t Au,
• SCD-023 intercepted 8.45 m averaging 1.4 g/t Au, including 1.85 m averaging 4.76 g/t Au,
• SCD-024 intercepted 5.7 m averaging 1.25 g/t Au, including 0.9 m averaging 6.22 g/t Au.

Assays of four additional core holes at El Colorado are pending and will be reported in due course.

A map accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e0c43a43-2804-4dbd-beac-3c80849e59c1

The El Colorado zone is located along an extensively mineralized east-west trending ridge in the southwestern part of the Cerro Caliche property. Drilling to date has outlined a gold mineralized zone approximately 300 meters long from north to south and 200 meters wide, which remains open to the northwest and southeast.

The cross-section image below of El Colorado demonstrates mineralization at relatively shallow depth due to the profile of the steep hillside in relation to the mineralization. Previously reported drill holes intercepted 12-meters averaging 11.22 g/t Au and 6-meters averaging 12.96 g/t Au.

Assays from four previous dill holes have been included in the cross-section for reference.

A map accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/83c72519-302c-401c-b3c4-9f9078dffc8d

El Colorado Zone – Assay Results

Cerro Caliche Project, Holes Composites with Cut-Off 0.15 Au g/t
Hole	Target		From	To	Interval	Au	Ag	AuEq
			(meters)			g/t	g/t	g/t
SCD-008	EL COLORADO		0.00	4.10	4.10	0.29	1.00	0.30
		and	35.35	40.60	5.25	0.80	5.00	0.87
		and	81.50	87.50	6.00	0.41	4.00	0.46
		and	101.95	113.65	11.70	0.92	2.00	0.94
		includes	108.05	112.60	4.55	1.84	2.00	1.87
		and	136.45	137.40	0.95	2.00	2.60	2.03
SCD-016	EL COLORADO		10.25	11.40	1.15	0.79	42.90	1.40
		and	18.45	27.55	9.10	0.34	2.00	0.37
		and	38.00	40.70	2.70	0.85	2.70	0.89
		and	156.85	168.10	11.25	1.08	2.80	1.12
		includes	162.20	163.20	1.00	2.88	2.00	2.91
		includes	167.50	168.10	0.60	11.50	4.20	11.56
		and	178.50	184.10	5.60	2.83	2.50	2.87
SCD-023	EL COLORADO		4.00	8.00	4.00	0.32	3.40	0.37
		and	10.00	12.00	2.00	0.93	5.40	1.01
		and	20.00	23.35	3.35	0.17	2.90	0.21
		and	49.70	58.15	8.45	1.40	1.60	1.41
		includes	52.30	54.15	1.85	4.76	3.40	4.81
		and	89.60	95.00	5.40	0.67	0.70	0.68
SCD-024	EL COLORADO		45.20	46.35	1.15	1.55	0.40	1.55
		and	49.90	55.60	5.70	1.25	3.60	1.30
		includes	51.15	52.05	0.90	6.22	6.90	6.32
		and	60.10	65.70	5.60	0.48	3.40	0.53

Assay intervals of the four previously reported reverse circulation drill holes included in El Colorado cross-section illustration are tabulated below to provide context.

Cerro Caliche Project, holes composites with cutoff 0.15 Au g/t
Hole	Target		From		To	Interval	Au	Ag	AuEq
			(meters)				g/t	g/t	g/t
SCR-036	EL COLORADO		6.10	10.67		4.57	4.67	1.90	4.69
		and	13.72	15.24		1.52	1.24	2.40	1.27
		and	25.91	30.48		4.57	0.41	1.00	0.43
		and	35.05	38.10		3.05	0.34	1.00	0.35
SCR-037	EL COLORADO		6.10	21.34		15.24	0.60	6.90	0.70
		includes	9.14	15.24		6.10	1.04	7.50	1.14
		and	102.11	106.68		4.57	0.32	1.50	0.34
Cerro Caliche Project, Holes Composites with Cut-Off 0.15 Au g/t
Hole	Target		From	To		Interval	Au	Ag	AuEq
			(meters)				g/t	g/t	g/t
SCR-044	EL COLORADO		13.72	16.76		3.04	0.58	4.00	0.64
		and	24.38	28.96		4.58	0.51	4.00	0.57
		and	48.77	60.96		12.19	11.22	5.90	11.30
		includes	51.82	57.91		6.09	21.58	8.20	21.70
		and	85.34	92.96		7.62	2.07	15.70	2.29
		includes	86.87	91.44		4.57	3.15	23.20	3.48
SCR-045	EL COLORADO		15.24	21.34		6.10	0.76	2.80	0.80
		and	41.15	45.72		4.57	0.34	4.30	0.40
		and	56.39	71.63		15.24	0.99	4.10	1.05
		includes	64.01	71.63		7.62	1.77	6.70	1.86

Continuation of the Core Drilling Program

Core drilling has been suspended until the New Year and is expected to recommence on January 4, 2021. A total of 24 HQ-sized holes were completed and assays for 11 of these holes are pending. An additional 11 PQ-sized core holes were drilled in the early part of the core drilling program specifically to supply mineralized material for metallurgical testing, essential to advance the Company’s plans to fast-track a proposed mine development program with a goal to achieve gold production by the end of 2021.

Japoneses Zone – Additional Results from Core and RC Drilling

At the Japoneses Zone, three core holes, SCD-001, SCD-002 and SCD-003, were completed to test for potential deeper extensions of the zone’s shallow epithermal mineralization. The targeted areas were about 200 meters lower than the zone’s drilled extent. The three 45-degree holes ranged from 370 to over 400 meters in length. SCD-001 intercepted 8 meters averaging 0.45 g/t Au beginning at 50.95 meters depth. SCD-OO2 encountered a wider interval of 21 meters averaging 0.41 g/t Au at 24.2 meters depth. These two reported intervals are in the upper part of the drill holes near the drill collars and they are part of the Chinos NW zone that extends the zone southeasterly by approximately 40 meters. SCD-003, which was collared at the northeastern-most extent of the Japoneses zone, was similar in trajectory and length to SCD-001 and SCD-002 and targeted conceptual deep high-grade gold vein systems which may have supplied the Japoneses shallow oxide gold mineralization. SCD-003 returned several narrow intervals of mineralization ranging from 0.212 to 0.978 g/t Au.

Assays from five additional RC drill holes from the Japoneses zone have been received. These drill holes, SCR-137 through SCR-140 and SCR-144, are important infill drill holes demonstrating continuous mineralization in gaps between prior drill holes.

Japoneses Zones- Assay Results

Cerro Caliche Project, holes composites with cutoff 0.15 Au g/t
Hole	Target		From	To	Interval	Au	Ag	AuEq
			meters			g/t
SCR-137	JAPONESES		3.05	16.76	13.71	0.23	0.60	0.24
		and	22.86	30.48	7.62	0.31	0.50	0.31
		and	47.24	60.96	13.72	0.47	0.30	0.47
		includes	57.91	59.44	1.53	1.72	0.50	1.72
Cerro Caliche Project, holes composites with cutoff 0.15 Au g/t
Hole	Target		From	To	Interval	Au	Ag	AuEq
			(meters)			g/t	g/t	g/t
SCR-138	JAPONESES		0.00	6.10	6.10	0.30	0.90	0.32
		and	18.29	22.86	4.57	0.32	1.30	0.34
		and	25.91	35.05	9.14	0.27	1.00	0.29
		and	45.72	60.96	15.24	0.40	0.30	0.41
SCR-139	JAPONESES		1.52	10.67	9.15	0.36	1.60	0.39
		and	21.34	24.38	3.04	0.45	0.50	0.46
		and	57.91	59.44	1.53	1.91	0.15	1.91
SCR-140	JAPONESES	and	68.58	71.63	3.05	0.68	45.40	1.33
		includes	70.10	71.63	1.53	1.12	87.00	2.37
		and	77.72	82.30	4.58	0.39	1.00	0.40
		and	86.87	108.20	21.33	0.47	4.60	0.54
		includes	97.54	99.06	1.52	1.08	39.00	1.63
		and	134.11	140.21	6.10	0.32	0.80	0.33
SCR-144	JAPONESES	and	21.34	24.38	3.04	0.27	3.00	0.31
		and	38.10	41.15	3.05	0.22	1.80	0.24
		and	71.63	97.54	25.91	0.42	2.80	0.46
		includes	73.15	74.68	1.53	2.32	2.80	2.36

Drill collar locations, azimuths and dips for the drill holes included in this release are provided in the table below and have been posted to the Company’s website for all drill holes.

Drill Collar Locations (NAD 1927 UTM Zone 12N)
Drill Hole	Zone	Easting	Northing	Elevation	Depth (m)	Dip	Azimuth
SCR-137	Japoneses	536750	3365102	1362	100.58	-45	235
SCR-138	Japoneses	536783	3365041	1375	82.3	-45	235
SCR-139	Japoneses	536811	3365063	1362	115.82	-45	235
SCR-140	Japoneses	536747	3365249	1360	161.54	-48	235
SCR-144	Japoneses	536790	3365288	1367	97.54	-50	235
SCD-008	El Colorado	536117	3364514	1299	140	-67	157
SCD-016	El Colorado	536184	3364649	1311	221.5	-45	199
SCD-023	El Colorado	536150	3364462	1258	101.85	-74	230
SCD-024	El Colorado	536164	3364521	1267	116.6	-84	158

Core Drilling Program – Initial Assessment and Future Plans

The additional holes at the El Colorado zone have added to an already intensely mineralized zone, while drilling results in other known mineralized zones have allowed us to not only refine the epithermal model, but also importantly, where to search for future high-grade targets. These results have indicated that several of the initial targets, such as those previously reported at the Sultan zone near the eastern boundary of the property, were below the previously projected boiling zone in the epithermal system. Therefore, as the location of the ideal boiling zone has been shown to be at higher elevations, priority is now being given to already identified and potential high-grade targets, which are at higher elevations on Cerro Caliche. As these targets are much closer and, in some cases, adjacent to Cerro Caliche’s shallow gold mineralization, the higher grade would form part of an expanded near-surface resource estimate.

These additional results will enable Sonoro to further refine and develop its plans to test additional high-grade targets located at the higher elevations, while concurrently expanding the mineralized zones. Priority targets for the high-grade drilling program, which is scheduled to continue at least until April 2021, are at the Cerro Caliche peak, Buena Suerte, Cabeza Blanca north, in addition to El Colorado.

Melvin Herdrick, Sonoro’s Vice President Exploration, stated, “We are happy to conclude the year with strong results from the Cerro Caliche drill program enabling us to evaluate the possibility of a potentially larger mine operation than previously discussed. The latest results at El Colorado show it to be a well-mineralized block with numerous wide veins and veinlet zones all shown as a network, including two blind vein zones that may help define the structural setting of the geometry of the mineralization at Cerro Caliche. I am very optimistic with the potential for the El Colorado mineralized zone and how it could ultimately add to and better define Cerro Caliche’s planned resource estimate.”

Kenneth MacLeod, Sonoro’s President and CEO, added, “The Sonoro Board is grateful for the superlative efforts of our technical team in Mexico in expanding the known mineralized zones and defining new mineralized zones for quantifying in the upcoming NI 43-101 resource report. Special thanks go to VP Exploration, Melvin Herdrick; VP Operations, Jorge Diaz; and Chief Geologist, Oscar Gonzalez.”

John Darch, Sonoro’s Chairman, concluded, “It has been an exceptional year for Sonoro as we continue to advance our dual drilling program and meet important early-stage milestones towards our goal of achieving production. Our strategy of continuing to explore and develop Cerro Caliche’s extensive shallow oxide gold mineralization has been successful, while our fast-track program to test the viability of our proposed 20,000 tpd mining operation is on schedule. Most importantly, the recent drill results continue to exceed our expectations and support our decision to evaluate a material increase in the conceptual capacity of an initial mining operation. We believe this production decision will be welcomed by all shareholders.”

Results from Abel Zone

In the Abel Vein zone located in the eastern part of the property, a scout exploratory core drill hole, SCD017, was completed. This hole cut the vein structural zone with narrow intercepts of 0.3 to 0.33 g/t Au that are not considered significant. The Abel zone has similar geochemistry to the Sultan zone and, like the Sultan zone, is interpreted to be below the Cerro Caliche epithermal system’s ideal boiling zone.

Quality Assurance/Quality Control (“QA/QC”) Measures and Analytical Procedures
Drill samples are collected with an airstream cyclone and passed into a splitter that divides each sample into quarters. The quartered samples are then bagged and sealed with identification. The sample group has blanks, standards and duplicates inserted into the sample stream.

Bureau Veritas collects the samples and transports them directly to the preparation laboratory in Hermosillo, Sonora. At the laboratory, part of each sample is reduced through crushing, splitting and pulverization. About 200 grams are sent by BV to their Vancouver, BC laboratory and dissolved in aqua regia for multi-element ICP analysis including silver. Of these samples, 30 grams undergo fire assay in Hermosillo for gold by reducing the fire assay to a concentrated button of material that is dissolved in acids and the gold content determined by atomic absorption.

Some samples were collected by ALS-Chemex and transported directly to the preparation laboratory in Hermosillo, Sonora. At the laboratory, part of each sample is reduced through crushing, splitting and pulverization from which 200 grams is sent to the ALS-Chemex assay laboratory in Vancouver. Thirty grams undergoes fire assay for gold with the resulting concentrated button of material produced is dissolved in acids and the gold is determined by atomic absorption. Another quantity of the sample is dissolved in four acids for an ICP multi-element analysis.

No QA/QC issues were noted with the results received from either laboratory.

Geologic Description
Cerro Caliche is located 45 kilometers east southeast of Magdalena de Kino in the Cucurpe-Sonora Mega-district of Sonora, Mexico. Multiple historic underground mines were developed in the concession including Cabeza Blanca, Los Cuervos, Japoneses, Las Abejas, Boluditos, El Colorado, Veta de Oro and Espanola. Mineralization types of the Cucurpe-Sonora Mega-district include variants of epithermal low sulfidation veins and related mineralized dikes and associated volcanic domes. Local altered felsic dikes cut the mineralized meta-sedimentary rock units and may be associated with mineralization both in the dikes and meta-sedimentary rocks.

Host rocks include Jurassic-Cretaceous meta-sedimentary rock units including argillite, shale, quartzite, limestone, quartz pebble conglomerate and andesite. Younger intrusive rock consisting of medium coarse-grained granodiorite-granite is present in the westerly parts of the concessions near the historic Cabeza Blanca Mine. It is apparent that veining cuts and pervasively alters the intrusive stock. Rhyolite occurs in irregular bodies distributed in higher elevations in the northerly part of the concession, including the Rincon area, where it occurs as flows, sills, dikes and rhyolite domes. Part of the rhyolite is mineralized and appears to be related to epithermal gold mineralization throughout the property.

Qualified Person Statement
Stephen Kenwood, P.Geo., a Director of Sonoro, is a Qualified Person within the context of National Instrument 43-101 (NI 43-101) and has read and approved this news release. Readers are cautioned that the presence of mineralization on historic mines adjacent to or on Cerro Caliche is not necessarily indicative of gold mineralization in the concessions held by the Company.

About Sonoro Gold Corp.
Sonoro Gold Corp. is a publicly listed exploration and development company with a portfolio of exploration-stage precious metal properties in Sonora State, Mexico. The Company has highly experienced operational and management teams with proven track records for the discovery and development of natural resource deposits.

On behalf of the Board of Sonoro Gold Corp.
Per:	“Kenneth MacLeod”
	Kenneth MacLeod
	President & CEO

For further information, please contact:
Sonoro Gold Corp. – Tel: (604) 632-1764
Email: [email protected]

Forward-Looking Statement Cautions

: This press release contains certain “forward-looking statements” within the meaning of Canadian securities legislation, relating to, among other things, the Company’s plans for the drilling of the above-described Cerro Caliche Concessions, located in the municipality of Cucurpe, Sonora, Mexico, and the Company’s future exploration and development plans for those properties, including statements regarding an anticipated increase in the current resource estimate for Cerro Caliche, a proposed 20,000 tonne per day HLMO, including a targeted December 2021 production start date, confirmation of the results of previous in-house column leach test results, the hoped for results of continued exploration drilling, including to test high-grade targets, and other material conditions set out above on which the Company’s development plans are dependent. Although the Company believes that such statements are reasonable based on current circumstances, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made and they involve a number of risks and uncertainties, including the possibility of unfavourable exploration and leach test results, unfavourable results of the contemplated PEA of the Cerro Caliche project, the lack of sufficient future financing to carry out exploration and development plans, and unanticipated changes in the legal, regulatory and permitting requirements for the Company’s exploration programs. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law or the policies of the TSX Venture Exchange. Readers are encouraged to review the Company’s complete public disclosure record on SEDAR at
www.sedar.com
.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
 

NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) — LF Capital Acquisition Corp. (NASDAQ: LFAC) (“LF Capital”) announced today that in connection with its proposed business combination (the “Business Combination”) with Landsea Homes Incorporated (“Landsea Homes”), Landsea Homes’ parent, Landsea Green Properties Co., Ltd. (“Landsea Green”), has obtained the approval of the Stock Exchange of Hong Kong Limited (“HKSE”) in accordance with the applicable requirements of the HKSE’s listing rules.

LF Capital expects all conditions to closing the Business Combination to be satisfied soon and accordingly anticipates that the Business Combination will close in the first half of January 2021.

Advisors

B. Riley Securities and Raymond James & Associates, Inc. are acting as financial advisors for LF Capital. B. Riley Securities and Barclays are acting as placement agents for LF Capital. Dechert LLP is acting as legal counsel for LF Capital.

Rothschild & Co is acting as exclusive financial advisor to Landsea Homes. Gibson, Dunn & Crutcher LLP is acting as legal counsel for Landsea Homes. Barclays is acting as capital markets advisor to Landsea Homes. Gateway Group is serving as communications advisor to Landsea Homes.

About LF Capital Acquisition Corp.

LF Capital Acquisition Corp. is a blank check company that was formed in 2018 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. For more information, please visit www.lfcapital.co.

About Landsea Homes Incorporated

Landsea Homes designs and builds best-in-class, high-performance homes and sustainable master-planned communities in some of the most desirable markets in the United States. The company has developed homes and communities in Arizona and throughout California in Silicon Valley, Los Angeles and Orange County.

Creating inspired places that reflect modern living, Landsea Homes builds suburban, single-family detached and attached homes, mid- and high-rise properties and master-planned communities to meet the diverse and ever-changing expectations and lifestyles of our homebuyers today and tomorrow.

Led by a veteran team of industry professionals who boast years of worldwide experience and deep local expertise, Landsea Homes is committed to positively enhancing the lives of our homebuyers, employees and stakeholders by creating an unparalleled lifestyle experience that is unmatched everywhere we build.

Landsea Homes is currently a wholly owned U.S. subsidiary of Landsea Green Group, an international homebuilder that thinks globally but operates locally. Operating on three continents including Europe, Asia and North America, Landsea Green’s deep knowledge and experience of building and living in different environments all over the world deliver homes that embrace the local lifestyle in which they are built. For more information, please visit landseahomes.com.

Important Information About the Business Combination and Where to Find It

In connection with the Business Combination, LF Capital filed a definitive proxy statement with the Securities and Exchange Commission (the “SEC”) on November 23, 2020 (the “Proxy Statement”). LF Capital mailed the Proxy Statement and other relevant documents to its stockholders beginning on or about November 27, 2020. LF Capital’s stockholders and other interested persons are advised to read the definitive proxy statement and any amendments thereto in connection with LF Capital’s solicitation of proxies for its special meeting of stockholders to be held to approve, among other things, the Business Combination, because these documents contain important information about LF Capital, Landsea Homes and the Business Combination. LF Capital’s stockholders may also obtain a copy of the definitive proxy statement as well as other documents filed with the SEC by LF Capital, without charge, at the SEC’s website located at www.sec.gov or by directing a request to: LF Capital Acquisition Corp., 600 Madison Avenue, Suite 1802, New York, NY 10022. The information contained on, or that may be accessed through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.

Participants in the Solicitation

LF Capital and its directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of LF Capital’s stockholders in connection with the proposed merger and related transactions. Investors and security holders may obtain more detailed information regarding the names and interests in the proposed transactions of LF Capital’s directors and officers in LF Capital’s filings with the SEC, including LF Capital’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, which was filed with the SEC on February 24, 2020 and such information in the preliminary proxy statement and amendments thereto filed with the SEC by LF Capital in connection with the proposed merger and related transactions.

Forward Looking Statements

This press release includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LF Capital’s management’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: the conditions to the completion of the merger, including the required approval by LF Capital’s stockholders, may not be satisfied on the terms expected or on the anticipated schedule; the parties’ ability to meet expectations regarding the timing and completion of the merger; the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement; the approval by LF Capital’s stockholders of an amendment to LF Capital’s organizational documents to extend the date by which LF Capital must complete its initial business combination in order to have adequate time to close the proposed transaction; the outcome of any legal proceedings that may be instituted against the Company related to the merger or the Merger Agreement; and the amount of the costs, fees, expenses and other charges related to the merger. LF Capital undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

No Offer or Solicitation

This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended.

LF Capital Contact:

Scott A. Reed
Chief Executive Officer and President
214-740-6112

Landsea Homes Contact:

John Ho
Chief Executive Officer
949-345-8080

Investor Relations Contact:

Cody Slach
Gateway Investor Relations
949-574-3860
[email protected]

STAMFORD, Conn., Dec. 18, 2020 (GLOBE NEWSWIRE) — Adoption of cloud-based IT has increased dramatically in the U.S. after the outbreak of the COVID-19 pandemic, with enterprises turning to service providers to help them move workloads to hyperscale providers like Amazon Web Services (AWS), according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.

The 2020 ISG Provider Lens™ AWS – Ecosystem Partners Report for the U.S. finds pandemic-related disruptions in workforces, in supplier and customer relationships, and in business operations have accelerated digital transformation efforts overall, including cloud adoption.

“The core goal for many enterprises in 2020 has been ‘more digital, more quickly,’” said Jan Erik Aase, director and global leader, ISG Provider Lens Research. “The scale of cloud adoption and use witnessed before 2020 is relatively minor compared to what most enterprises and providers are now experiencing.”

According to the latest ISG Index™, global annual contract value (ACV) for the cloud-based as-a-service market—including both infrastructure-as-a-service (IaaS) and software-as-a-service (SaaS)—was up nearly 15 percent, to $24.4 billion, in the first nine months of 2020. The bulk of the growth came from IaaS, up nearly 20 percent, to $17.8 billion. In the Americas, as-a-service ACV was up 40 percent, to $13.3 billion, during the same period, with IaaS up 58 percent, to $8.9 billion.

In the past, the ISG Provider Lens report notes, many U.S. enterprises kept their large-scale, complex and customized enterprise software environments partially on premises, but the pandemic has pushed them toward moving most of their applications and databases onto AWS and other hyperscale platforms. The broad availability of affordable and adaptable container technologies such as Kubernetes and Docker have accelerated this move to the cloud.

The report also finds many AWS service providers moving beyond helping their customers adopt cloud technologies to helping them refine their digital business strategies, with a focus on improved business outcomes. These consulting engagements are leading to customer interest in change management, design thinking and DevOps.

In addition, U.S. enterprises are increasingly focused on data analytics and machine learning, as their work-from-anywhere environments are spurring a huge wave of data discovery, the report says. Business leaders are beginning to pay attention to what data exists across all parts of the enterprise, instead of in specific functional areas. With this new holistic focus on enterprise data, including data generated by a growing range of IoT devices, enterprises are seeking AWS service providers that can help them with data analytics.

Meanwhile, managed services providers for AWS are rapidly expanding into areas traditionally dominated by systems integrators, the report adds. The pandemic’s impact on cloud adoption and integration requirements has pushed MSPs into new areas, such as integration and security.

The 2020 ISG Provider Lens™ AWS – Ecosystem Partners Report for the U.S. evaluates the capabilities of 65 providers across six quadrants: Consulting Services Providers, Data Analytics and Machine Learning, Internet of Things, Migration and Container Solutions, Managed Services Providers, and SAP Workloads.

The report names Accenture, Capgemini, Cognizant, Deloitte and Wipro as leaders in all six quadrants and DXC Technology and Infosys as leaders in five. IBM, Rackspace Technology and TCS are named leaders in four quadrants, and Tech Mahindra is named a leader in three. HCL and Hexaware are named leaders in two quadrants, and HPE, LTI, Mindtree, Mphasis, NTT DATA, PwC and Virtusa were named leaders in one.

In addition, LTI was named a Rising Star—companies with “promising portfolios” and “high future potential” by ISG’s definition—in three quadrants. Virtusa was named a Rising Star in two quadrants, and 2nd Watch, DXC Technology, Lemongrass Consulting, Mphasis and Tech Mahindra were named Rising Stars in one.

Customized versions of the report are available from Hexaware, Mphasis, Tech Mahindra and TO THE NEW.

The 2020 ISG Provider Lens™ AWS – Ecosystem Partners Report for the U.S. is available to subscribers or for one-time purchase on this webpage.

About ISG Provider Lens™ Research

The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG’s global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG’s enterprise clients. The research currently covers providers offering their services globally, across Europe and Latin America, as well as in the U.S., Germany, Switzerland, the U.K., France, the Nordics, Brazil and Australia/New Zealand, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types.

Starting this year, each ISG Provider Lens™ study will include a Global Summary to help enterprise subscribers better understand provider capabilities across all geographic markets covered by that study. All ISG Provider Lens™ reports also will now include an Enterprise Context feature to help executives quickly identify key insights related to their roles and responsibilities.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

# # #

Will Thoretz
Information Services Group, Inc. 
+1 203 517 3119
[email protected]

Jim Baptiste
Matter Communications for ISG
+1 978 518 4527
[email protected]

– Over $625 million of proceeds raised in the transaction will support the production and launch of electric vehicles (EV) featuring Canoo’s advanced EV platform technology –

– 99.97% of Public Shareholders Elected to retain GOEV stock –

– Shareholders Are Reminded to Vote in Favor of the Business Combination –

NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) — Hennessy Capital Acquisition Corp. IV (NASDAQ: HCAC, HCACW, HCACU) (“HCAC”) today announced that, as of the deadline for redemption elections in connection with the pending business combination (the “Business Combination”) with Canoo Holdings Ltd. (“Canoo”), over 99.97% (or approximately $306 million) of funds will remain in HCAC’s trust account as of closing. As a result, over $625 million of proceeds will be available upon the closing of the Business Combination.

Tony Aquila, Executive Chairman of Canoo commented, “We are grateful to investors for supporting our vision. With more than $625 million available to us upon close of the transaction, we have adequate resources to execute our go-to-market strategy. We will bring consumers and businesses what they need to enjoy the full benefits of our multi-purpose EV platform.”

Daniel J. Hennessy, Chairman and Chief Executive Officer of HCAC added, “This transaction has enabled Canoo to accelerate key initiatives, including its B2B (business to business) multi-purpose delivery vehicle which it revealed yesterday. This important B2B vehicle targets a huge addressable market and represents a compelling opportunity for investors in this category.”

HCAC’s stockholders of record at the close of business on October 27, 2020 (the “Record Date”) are entitled to vote the shares of common stock of HCAC owned by them at the special meeting of HCAC stockholders on December 21, 2020 (the “Special Meeting”) to approve the Business Combination. In connection with the Business Combination, HCAC filed its registration statement on Form S-4 (File No. 333-248923) (as amended, the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”), which includes the definitive proxy statement/prospectus. The Registration Statement was declared effective by the SEC on December 4, 2020, and the definitive proxy statement/prospectus and proxy card were mailed shortly thereafter to HCAC’s stockholders of record as of the Record Date. If any of HCAC’s stockholders have not received the Proxy Statement, such stockholder should confirm their proxy’s status with their broker, or call HCAC’s proxy solicitor, Morrow Sodali LLC, at (800) 662-5200 for help (banks and brokers can call collect at (203) 658-9400).

The Business Combination is expected to close as soon as practicable after the Special Meeting, subject to the satisfaction of the applicable closing conditions. Upon the closing of the Business Combination, the combined company will be renamed “Canoo Inc.” and its common stock and warrants will trade on The Nasdaq Global Select Market (“Nasdaq”) under the ticker symbols “GOEV” and “GOEVW,” respectively.

About Hennessy Capital Acquisition Corp. IV

Hennessy Capital Acquisition Corp. IV is a special purpose acquisition company (or SPAC) which raised $300 million in its IPO in March 2019 and is listed on the Nasdaq Stock Market (NASDAQ: HCAC, HCACU, HCACW). HCAC was founded by Daniel J. Hennessy to pursue an initial business combination, with a specific focus on businesses in the industrial, technology and infrastructure sectors. For more information, please visit www.hennessycapllc.com.

About Canoo

Canoo is a Los Angeles-based company that has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design, pioneering technologies, and a unique business model that defies traditional ownership to put customers first. Distinguished by its experienced team – totaling over 350 employees from leading technology and automotive companies – Canoo has designed a modular platform purpose-built to deliver maximum vehicle interior space and adaptable to support a wide range of vehicle applications for consumers and businesses.

For more information, please visit www.canoo.com.

For Canoo press materials, including photos, please visit press.canoo.com.

For investors, please visit investors.canoo.com.

Additional Information About the Proposed Business Combination and Where to Find It

In connection with the Business Combination, HCAC filed the Registration Statement with the SEC, which includes the definitive proxy statement to be distributed to holders of HCAC’s common stock in connection with HCAC’s solicitation of proxies for the vote by HCAC’s stockholders with respect to the Business Combination and other matters as described in the Registration Statement and a prospectus relating to the offer of the securities to be issued to the equity holders of Canoo in connection with the Business Combination. The Registration Statement was declared effective by the SEC on December 4, 2020 and the definitive proxy statement/prospectus and other relevant documents have been mailed to HCAC’s stockholders as of the Record Date. HCAC’s stockholders and other interested persons are advised to read the definitive proxy statement / prospectus, in connection with HCAC’s solicitation of proxies for the Special Meeting to be held to approve, among other things, the Business Combination, because these documents contain important information about HCAC, Canoo and the Business Combination. Stockholders may also obtain a copy of the definitive proxy statement/prospectus, as well as other documents filed with the SEC regarding the Business Combination and other documents filed with the SEC by HCAC, without charge, at the SEC’s website located at www.sec.gov or by directing a request to Nicholas A. Petruska, Executive Vice President, Chief Financial Officer, 3415 N. Pines Way, Suite 204, Wilson, Wyoming 83014 or by telephone at (307) 201-1903.

Participants in the Solicitation

HCAC, Canoo and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from HCAC’s stockholders in connection with the Business Combination. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of HCAC’s stockholders in connection with the Business Combination, including a description of their direct and indirect interests, is set forth in the Registration Statement filed with the SEC. You can find more information about HCAC’s directors and executive officers in the Registration Statement. You may obtain free copies of these documents from the sources indicated above.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, expectations and timing related to commercial product launches, ability to accelerate Canoo’s go-to-market strategy and capitalize on commercial opportunities, potential benefits of the transaction and the potential success of Canoo’s go-to-market strategy, and expectations related to the terms and timing of completing the transaction. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Canoo’s and HCAC’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Canoo and HCAC. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions; the inability of the parties to successfully or timely consummate the Business Combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the Business Combination or that the approval of the stockholders of HCAC or Canoo is not obtained; failure to realize the anticipated benefits of the Business Combination; risks relating to the uncertainty of the projected financial information with respect to Canoo; risks related to the rollout of Canoo’s business and the timing of expected business milestones and commercial launch; risks related to future market adoption of Canoo’s offerings; risks related to Canoo’s go-to-market strategy and subscription business model; the effects of competition on Canoo’s future business; the amount of redemption requests made by HCAC’s public stockholders; the ability of HCAC or the combined company to issue equity or equity-linked securities in connection with the Business Combination or in the future, and those factors discussed in HCAC’s final prospectus filed on March 4, 2019, Annual Report on Form 10-K for the fiscal year ended December 31, 2019, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020 and the Registration Statement, and the definitive proxy statement/prospectus contained therein, in each case, under the heading “Risk Factors,” and other documents of HCAC filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither HCAC nor Canoo presently know or that HCAC and Canoo currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect HCAC’s and Canoo’s expectations, plans or forecasts of future events and views as of the date of this press release. HCAC and Canoo anticipate that subsequent events and developments will cause HCAC’s and Canoo’s assessments to change. However, while HCAC and Canoo may elect to update these forward-looking statements at some point in the future, HCAC and Canoo specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing HCAC’s and Canoo’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

No Offer or Solicitation

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

Contacts

For Canoo / Media Relations

Stacy Morris
[email protected]

Investor Relations

Mike Callahan / Tom Cook
[email protected]